do you feel hungry on tirzepatide Why Am I Still & How Can I Stay Satisfied? so here’s the thing:, I

The recently initiated large-sized FLOW trial investigating the effects of semaglutide on hard renal outcomes in patients with DKD will provide clarity whether GLP-1 receptor agonists may reduce the burden of DKD in addition to their other beneficial metabolic and cardiovascular effects.

Approximate equivalency suggests 5mg tirzepatide may compare to 2mg semaglutide, but individual response depends on metabolic biomarkers, genetic predispositions, and provider assessment

Individualize escalation (e.g., 0.75 mg instead of jumping from 0.5 mg to 1.0 mg) when appropriate

Concerns also exist about weight regain after discontinuing the medication

It is commonly available as a once-weekly injection.